Statement re. Share Price Movement

Cambridge, UK - 25th October 2019

Nuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs notes the recent share price movement and press reports.

Download News

Back to all News